Figure 2.
Trends in serum creatinine (A), blood urea nitrogen (B), serum glucose (C), and mean arterial pressure (D) before and after SGLT‐2i therapy. SGLT‐2i, sodium glucose cotransporter 2 inhibitor.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.